These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an Ahmadi K; Farasat A; Rostamian M; Johari B; Madanchi H J Biomol Struct Dyn; 2022 Aug; 40(12):5566-5576. PubMed ID: 33438525 [TBL] [Abstract][Full Text] [Related]
3. Repurposing fusion inhibitor peptide against SARS-CoV-2. Efaz FM; Islam S; Talukder SA; Akter S; Tashrif MZ; Ali MA; Sufian MA; Parves MR; Islam MJ; Halim MA J Comput Chem; 2021 Dec; 42(32):2283-2293. PubMed ID: 34591335 [TBL] [Abstract][Full Text] [Related]
4. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors. Romeo A; Iacovelli F; Falconi M Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126 [TBL] [Abstract][Full Text] [Related]
5. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an Pandey P; Rane JS; Chatterjee A; Kumar A; Khan R; Prakash A; Ray S J Biomol Struct Dyn; 2021 Oct; 39(16):6306-6316. PubMed ID: 32698689 [TBL] [Abstract][Full Text] [Related]
6. Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2. Martin WR; Cheng F J Proteome Res; 2020 Nov; 19(11):4670-4677. PubMed ID: 32907334 [TBL] [Abstract][Full Text] [Related]
7. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states. Peters MH; Bastidas O; Kokron DS; Henze CE PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884 [TBL] [Abstract][Full Text] [Related]
8. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Kumar Y; Singh H; Patel CN J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274 [TBL] [Abstract][Full Text] [Related]
10. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study. Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454 [TBL] [Abstract][Full Text] [Related]
11. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex. Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435 [TBL] [Abstract][Full Text] [Related]
12. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease. Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685 [TBL] [Abstract][Full Text] [Related]
13. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity. Zhu Y; Yu D; Yan H; Chong H; He Y J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627 [TBL] [Abstract][Full Text] [Related]
15. Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein. Deganutti G; Prischi F; Reynolds CA J Comput Aided Mol Des; 2021 Feb; 35(2):195-207. PubMed ID: 33103220 [TBL] [Abstract][Full Text] [Related]
16. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach. Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467 [TBL] [Abstract][Full Text] [Related]
17. Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses Vishwakarma P; Yadav N; Rizvi ZA; Khan NA; Chiranjivi AK; Mani S; Bansal M; Dwivedi P; Shrivastava T; Kumar R; Awasthi A; Ahmed S; Samal S Front Immunol; 2021; 12():613045. PubMed ID: 33841395 [TBL] [Abstract][Full Text] [Related]
18. Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2). Egieyeh S; Egieyeh E; Malan S; Christofells A; Fielding B PLoS One; 2021; 16(1):e0245258. PubMed ID: 33417604 [TBL] [Abstract][Full Text] [Related]
19. COVID-19: docking-based virtual screening and molecular dynamics study to identify potential SARS-CoV-2 spike protein inhibitors from plant-based phenolic compounds. Moradkhani S; Farmani A; Saidijam M; Taherkhani A Acta Virol; 2021; 65(3):288-302. PubMed ID: 34565157 [TBL] [Abstract][Full Text] [Related]
20. ACE-2-Derived Biomimetic Peptides for the Inhibition of Spike Protein of SARS-CoV-2. Panda SK; Sen Gupta PS; Biswal S; Ray AK; Rana MK J Proteome Res; 2021 Feb; 20(2):1296-1303. PubMed ID: 33472369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]